Search results
Novavax Kickstarts Phase 2 Trial For COVID-19-Flu Combo, Stand-Alone Flu Vaccine Candidates
Benzinga via Yahoo Finance· 1 year agoNovavax Inc (NASDAQ: NVAX) has initiated a Phase 2 trial for its COVID-19-Influenza Combination...
Novavax to pause RSV vaccine trial, assess pipeline
Yahoo Finance via AOL· 1 year agoNovavax (NVAX) is facing serious headwinds going into 2023 with the pandemic demand waning and new leadership changes, even as it celebrates a historic...
Novavax CEO eyes next batch of COVID-19 vaccines after CDC approval
Yahoo Finance via AOL· 2 years agoNovavax passed the finish line to gain authorization for its COVID-19 vaccine, and its first...
FDA advisory panel to consider approving fourth COVID-19 vaccine, this one from Maryland's Novavax
USA TODAY via Yahoo News· 2 years agoA federal vaccine advisory committee meets Tuesday to decide whether adult Americans could soon get...
FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines
CBS News via Yahoo News· 2 years agoThe Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...
With old-school technology, can Novavax win over COVID vaccine skeptics?
LA Times via Yahoo News· 2 years agoA vial of the Novavax COVID-19 vaccine is ready for use in a Phase 3 clinical trial in London....
U.S. FDA flags risk of heart inflammation after Novavax COVID vaccine
Reuters via Yahoo News· 2 years ago(Reuters) -The U.S. Food and Drug Administration has raised concerns about a possible risk of heart...
What’s in the Novavax Vaccine? Experts Break It All Down
Prevention via Yahoo News· 2 years agoThe Food and Drug Administration has authorized Novavax’s COVID-19 vaccine for use in the U.S....
Novavax's Second Booster With Omicron Adapted COVID-19 Shot Shows Encouraging Immune Responses
Benzinga via Yahoo Finance· 1 year agoNovavax Inc (NASDAQ: NVAX) announced topline results from its Phase 3 trial of updated COVID-19 shot...
Novavax Just Dropped a Bombshell on Investors: Even Management Is Questioning Its Future
Motley Fool· 1 year agoNovavax (NASDAQ: NVAX) faces an uncertain future ahead as the need for COVID-19 vaccines diminishes....